Liquidia Technologies (LQDA) had the lowest return in September 2026 by a mid-cap US stock, returning -55.3%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Liquidia Technologies (LQDA) | September 2026 | -55.3% |
Xenon Pharmaceuticals (XENE) | September 2026 | -38.51% |
Dyne Therapeutics (DYN) | September 2026 | -35.53% |
ServiceTitan, Inc Class A Common Stock (TTAN) | September 2026 | -32.31% |
Uipath (PATH) | September 2026 | -30.18% |
ACADIA Pharmaceuticals (ACAD) | September 2026 | -30.13% |
Avis Budget (CAR) | September 2026 | -27.32% |
Navan, Inc Class A Common Stock (NAVN) | September 2026 | -26.45% |
Enova International (ENVA) | September 2026 | -26.22% |
Ionis Pharmaceuticals (IONS) | September 2026 | -26.04% |
Braze (BRZE) | September 2026 | -25.75% |
Webull (BULL) | September 2026 | -25.13% |
Almonty Industries Inc Common Shares (ALM) | September 2026 | -23.64% |
MGM Resorts International (MGM) | September 2026 | -23.62% |
Lamb Weston (LW) | September 2026 | -23.32% |
Chewy (CHWY) | September 2026 | -22.91% |
Versant Media (VSNT) | September 2026 | -22.78% |
NGL Energy Partners (NGL) | September 2026 | -22.42% |
Comstock Resources (CRK) | September 2026 | -22.12% |
Klaviyo (KVYO) | September 2026 | -21.51% |
AutoNation (AN) | September 2026 | -21.43% |
Zillow (ZG) | September 2026 | -21.31% |
Immunome (IMNM) | September 2026 | -21.01% |
Enliven Therapeutics (ELVN) | September 2026 | -20.95% |
H&R Block (HRB) | September 2026 | -20.77% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.